You have successfully sign out
Loading...
Harrow Health, Inc. 11.875% Senior Notes due 2027
HROWM
Company Description
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Â
NASDAQ
26.45USD
-0.20Â ( -0.75%)
After-hours 26.75$
0.30 (1.13%)Market Closed (as of Feb 28, 21:00 EDT)
Relative Strenght
79
Volume Buzz
-92%
Earning Acce
Yes
Dist 52w H.
5%
